Xiaomin Wang
Anyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial.
Journal: Future oncology (London, England)
Published: March 04, 2026
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 04, 2025
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCC.
Journal: Future oncology (London, England)
Published: July 30, 2025
Impact of consolidation immunotherapy after definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a real-world multicenter study.
Journal: International immunopharmacology
Published: May 27, 2025
A machine learning approach for radiation pneumonitis prediction in elderly esophageal cancer patients by integrating baseline computed tomography radiomics, dosiomics, and clinical characteristics.
Journal: Physics and imaging in radiation oncology
Published: May 14, 2025
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study.
Journal: Cancer biology & therapy
Published: May 14, 2025
Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety.
Journal: Biomolecules & biomedicine
Published: December 04, 2024
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial.
Journal: International journal of cancer
Published: December 03, 2024
Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial.
Journal: Radiation oncology (London, England)
Published: July 10, 2024
A novel risk stratification system for primary small-cell carcinoma of the esophagus: indication for prognostication and staging.
Journal: Journal of the National Cancer Center
Published: March 30, 2024
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: November 05, 2023
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Journal: JAMA network open
Published: May 17, 2023
Last Updated: 09/26/2026